Advertisement

Non-Skull Base Head and Neck Cancer

  • Farzan Siddiqui
  • David Raben
  • Sue S. Yom
  • Jiade J. Lu
  • Min Yao
Part of the Medical Radiology book series (MEDRAD)

Abstract

The standard treatment for non-skull base head and neck cancer is surgery, radiation therapy, chemotherapy, or various combinations of the above. Treatment options are often limited in patients with recurrence after radiation therapy. Although reirradiation can be offered there is an increased risk of serious complications. Stereotactic body radiation therapy (SBRT) has been used as a boost or salvage therapy for head and neck cancer in the skull base, such as nasopharyngeal carcinoma, with promising results. The use of stereotactic body radiation therapy for head and neck cancer in sites outside of the base of skull region is emerging. This chapter review will highlight the technical and clinical advances in SBRT for non-skull base head and neck cancer.

Keywords

Neck Cancer Intensity Modulate Radiation Therapy Stereotactic Body Radiation Therapy Gross Tumor Volume Radiation Therapy Oncology Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Conflict of Interest

There are no potential conflicts of interest among the authors and this manuscript. There are no financial or non-financial competing interests. This manuscript has been seen, read, and agreed upon in its content by all designated authors. This manuscript has not been submitted or published elsewhere.

References

  1. Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, Schuller DE, Forastiere AA (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21(1):92–98PubMedCrossRefGoogle Scholar
  2. Adler JR, Jr., Chang SD, Murphy MJ, Doty J, Geis P, Hancock SL (1997) The Cyberknife: a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg 69(1–4 Pt 2):124–128Google Scholar
  3. Ali I, Tubbs J, Hibbitts K, Algan O, Thompson S, Herman T, Ahmad S (2010) Evaluation of the setup accuracy of a stereotactic radiotherapy head immobilization mask system using kV on-board imaging. J Appl Clin Med Phys 11(3):3192PubMedGoogle Scholar
  4. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick Avan Glabbeke M (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945–1952Google Scholar
  5. Berson AM, Stein NF, Riegel AC, Destian S, Ng T, Tena LB, Mitnick RJ, Heiba S (2009) Variability of gross tumor volume delineation in head-and-neck cancer using PET/CT fusion, Part II: the impact of a contouring protocol. Med Dosim 34(1):30–35Google Scholar
  6. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354(6):567–578PubMedCrossRefGoogle Scholar
  7. Bradley JA, Paulson ES, Ahunbay E, Schultz C, Li XA, Wang D (2011) Dynamic MRI analysis of tumor and organ motion during rest and deglutition and margin assessment for radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys (in press)Google Scholar
  8. Brenner DJ (2008) The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18(4):234–239PubMedCrossRefGoogle Scholar
  9. Calais G, Alfonsi M, Bardet E, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Bertrand P (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91(24):2081–2086PubMedCrossRefGoogle Scholar
  10. Cengiz M, Ozyigit G, Yazici G, Dogan A, Yildiz F, Zorlu F, Gurkaynak M, Gullu IH, Hosal SA, kyol F (2010) Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors. Int J Radiat Oncol Biol PhysGoogle Scholar
  11. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944PubMedCrossRefGoogle Scholar
  12. Daisne JF, Duprez T, Weynand B, Lonneux M, Hamoir M, Reychler H, Gregoire V (2004) Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233(1):93–100PubMedCrossRefGoogle Scholar
  13. Dandekar P, Partridge M, Kazi R, Nutting C, Harrington K, Newbold K (2010) Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer. Indian J Cancer 47(3):260–266PubMedCrossRefGoogle Scholar
  14. De Crevoisier R, Bourhis J, Domenge C, Wibault P, Koscielny S, Lusinchi A, Mamelle G, Janot F, Julieron M, Leridant AM, Marandas P, Armand JP, Schwaab G, Luboinski BE, Schwege F (1998) Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients. J Clin Oncol 16(11):3556–3562PubMedGoogle Scholar
  15. De Crevoisier R, Domenge C, Wibault P, Koscielny S, Lusinchi A, Janot F, Bobin S, Luboinski B, Eschwege F, Bourhis J (2001) Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma. Cancer 91(11):2071–2076PubMedCrossRefGoogle Scholar
  16. Droege RT, Bjarngard BE (1979a) Metal screen-film detector MTF at megavoltage X-ray energies. Med Phys 6(6):515–518CrossRefGoogle Scholar
  17. Droege RT, Bjarngard BE (1979b) Influence of metal screens on contrast in megavoltage X-ray imaging. Med Phys 6(6):487–493CrossRefGoogle Scholar
  18. Duprez F, Madani I, Bonte K, Boterberg T, Vakaet L, Derie C, De Gersem W, De Neve W (2009) Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory. Radiother Oncol 93(3):563–569PubMedCrossRefGoogle Scholar
  19. Feldkamp IA, Davis LC, Kress JW (1984) Practical cone-beam algorithm. J Opt Soc Am A 1(6):612–619CrossRefGoogle Scholar
  20. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang KK (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48(1):7–16Google Scholar
  21. Fuks Z, Kolesnick R (2005) Engaging the vascular component of the tumor response. Cancer Cell 8(2):89–91PubMedCrossRefGoogle Scholar
  22. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300(5622):1155–1159PubMedCrossRefGoogle Scholar
  23. Heron DE (2009) Stereotactic body radiation therapy for recurrent head & neck cancers: rethinking nonoperative salvage strategies. Future Oncol 5(9):1321–1325PubMedCrossRefGoogle Scholar
  24. Heron DE, Rwigema JC, Gibson MK, Burton SA, Quinn AE, Ferris RL (2010) Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study. Am J Clin Oncol 34(2):165–172Google Scholar
  25. Heron DE, Rwigema JC, Gibson MK, Burton SA, Quinn A, Ferris RL (2011) Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study. Am J Clin Oncol 34(2):165–172PubMedGoogle Scholar
  26. Hong LX, Chen CC, Garg M, Yaparpalvi R, Mah D (2009) Clinical experiences with onboard imager KV images for linear accelerator-based stereotactic radiosurgery and radiotherapy setup. Int J Radiat Oncol Biol Phys 73(2):556–561PubMedCrossRefGoogle Scholar
  27. Jaffray DA, Siewerdsen JH, Wong Martinez JW, Martinez AA (2002) Flat-panel cone-beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys 53(5):1337–1349PubMedCrossRefGoogle Scholar
  28. Janot F, de Raucourt D, Benhamou E, Ferron C, Dolivet G, Bensadoun RJ, Hamoir M, Gery B, Julieron M, Castaing M, Bardet E, Gregoire V, Bourhis J (2008) Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol 26(34):5518–5523PubMedCrossRefGoogle Scholar
  29. Jin JY, Ryu S, Faber K, Mikkelsen T, Chen Q, Li S, Movsas B (2006) 2D/3D image fusion for accurate target localization and evaluation of a mask based stereotactic system in fractionated stereotactic radiotherapy of cranial lesions. Med Phys 33(12):4557–4566PubMedCrossRefGoogle Scholar
  30. Kasperts N, Slotman B, Leemans CR, Langendijk JA (2005) A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol 41(3):225–243PubMedCrossRefGoogle Scholar
  31. Kawaguchi K, Sato K, Horie A, Iketani S, Yamada H, Nakatani Y, Sato J, Hamada Y (2010) Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinoma. Radiat Oncol 5:51PubMedCrossRefGoogle Scholar
  32. Kirkpatrick JP, Meyer JJ, Marks LB (2008) The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 18(4):240–243PubMedCrossRefGoogle Scholar
  33. Kodani N, Yamazaki H, Tsubokura T, Shiomi H, Kobayashi K, Nishimura T, Aibe N, Ikeno H (2010) Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. J Radiat Res (Tokyo)Google Scholar
  34. Kodani N, Yamazaki H, Tsubokura T, Shiomi H, Kobayashi K, Nishimura T, Aibe N, Ikeno H (2011) Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. J Radiat Res (Tokyo) 52(1):24–31CrossRefGoogle Scholar
  35. Kolotas C, Tselis N, Sommerlad M, Roddiger S, Schnabel T, Baltas D, Kalogera-Fountzila A, Fountzilas G, Zamboglou N (2007) Reirradiation for recurrent neck metastases of head-and-neck tumors using CT-guided interstitial 192Ir HDR brachytherapy. Strahlenther Onkol 183(2):69–75PubMedCrossRefGoogle Scholar
  36. Langendijk JA, Bourhis J (2007) Reirradiation in squamous cell head and neck cancer: recent developments and future directions. Curr Opin Oncol 19(3):202–209PubMedCrossRefGoogle Scholar
  37. Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, Wong S, Ang K (2007) Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol 25(30):4800–4805Google Scholar
  38. Lee N, Chan K, Bekelman JE, Zhung J, Mechalakos J, Narayana A, Wolden S, Venkatraman ES, Pfister D, Kraus D, Shah J, Zelefsky MJ (2007) Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 68(3):731–740PubMedCrossRefGoogle Scholar
  39. Leksell L (1951) The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 102(4):316–319PubMedGoogle Scholar
  40. Leksell L, Lindquist C, Adler JR, Leksell D, Jernberg B, Steiner L (1987) A new fixation device for the Leksell stereotaxic system. Technical note. J Neurosurg 66(4):626–629Google Scholar
  41. Lo SS, Dawson LA, Kim EY, Mayr NA, Wang JZ, Huang Z, Cardenes HR (2010a) Stereotactic body radiation therapy for hepatocellular carcinoma. Discov Med 9(48):404–410Google Scholar
  42. Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, Teh BS, McGarry RC, Cardenes HR, Timmermann RD (2010b) Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 7(1):44–54CrossRefGoogle Scholar
  43. Lo SS, Sahgal A, Wang JZ, Mayr NA, Sloan A, Mendel E, Chang EL (2010c) Stereotactic body radiation therapy for spinal metastases. Discov Med 9(47):289–296Google Scholar
  44. Lo SS, Teh BS, Mayr NA, Olencki TE, Wang JZ, Grecula JC, Lu JJ, Timmerman RD (2010d) Stereotactic body radiation therapy for oligometastases. Discov Med 10(52):247–254Google Scholar
  45. Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y, Deng XW, Lu LX, Huang SM, Zeng ZF, Lin CG, Lu HH, Chiu JK, Carpenter LS, Grant WH 3rd, Woo SY, Cui NJ, Butler EB (2004) Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 58(3):682–687PubMedCrossRefGoogle Scholar
  46. Mackie TR, Holmes T, Swerdloff S, Reckwerdt P, Deasy JO, Yang J, Paliwal B, Kinsella T (1993) Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys 20(6):1709–1719PubMedCrossRefGoogle Scholar
  47. McDonald MW, Moore MG, Johnstone PA (2011) Risk of carotid blowout after reirradiation of the head and neck: a systematic review. Int J Radiat Oncol Biol Phys (in press)Google Scholar
  48. Moore CS, Liney GP, Beavis AW (2004) Quality assurance of registration of CT and MRI data sets for treatment planning of radiotherapy for head and neck cancers. J Appl Clin Med Phys 5(1):25–35PubMedCrossRefGoogle Scholar
  49. Morin O, Gillis A, Chen J, Aubin M, Bucci MK, Roach M, 3rdPouliot J (2006) Megavoltage cone-beam CT: system description and clinical applications. Med Dosim 31(1):51–61Google Scholar
  50. Nakamoto Y, Tamai K, Saga T, Higashi T, Hara T, Suga T, Koyama T, Togashi K (2009) Clinical value of image fusion from MR and PET in patients with head and neck cancer. Mol Imaging Biol 11(1):46–53PubMedCrossRefGoogle Scholar
  51. Park C, Papiez L, Zhang S, Story M, Timmerman RD (2008) Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 70(3):847–852PubMedCrossRefGoogle Scholar
  52. Pignon JP, le Maitre A, Maillard E, Bourhis J (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiother Oncol 92(1):4–14PubMedCrossRefGoogle Scholar
  53. Popovtzer A, Gluck I, Chepeha DB, Teknos TN, Moyer JS, Prince ME, Bradford CR, Eisbruch A (2009) The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. Int J Radiat Oncol Biol Phys 74(5):1342–1347PubMedCrossRefGoogle Scholar
  54. Prevost JB, de Boer H, Poll J, Voet P, Levendag P (2008) Analysis of the motion of oropharyngeal tumors and consequences in planning target volume determination. Radiother Oncol 87(2):268–273PubMedCrossRefGoogle Scholar
  55. Riegel AC, Berson AM, Destian S, Ng T, Tena LB, Mitnick RJ, Wong PS (2006) Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. Int J Radiat Oncol Biol Phys 65(3):726–732PubMedCrossRefGoogle Scholar
  56. Roh KW, Jang JS, Kim MS, Sun DI, Kim BS, Jung SL, Kang JH, Yoo EJ, Yoon SC, Jang HS, Chung SM, Kim YS (2009) Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 74(5):1348–1355PubMedCrossRefGoogle Scholar
  57. Rwigema JC, Heron DE, Ferris RL, Andrade RS, Gibson MK, Yang Y, Ozhasoglu C, Argiris AE, Grandis JR, Burton SA (2010) The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy. Am J Clin Oncol 34(4):372–379CrossRefGoogle Scholar
  58. Schinagl DA, Vogel WV, Hoffmann AL, van Dalen JA, Oyen WJ, Kaanders JH (2007) Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. Int J Radiat Oncol Biol Phys 69(4):1282–1289PubMedCrossRefGoogle Scholar
  59. Sher DJ, Haddad RI, Norris CM Jr, Posner MR, Wirth LJ, Goguen LA, Annino D, Balboni T, Allen A, Tishler RB (2010) Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer. Cancer 116(20):4761–4768PubMedCrossRefGoogle Scholar
  60. Siddiqui F, Patel M, Khan M, McLean S, Dragovic J, Jin JY, Movsas B, Ryu S (2009) Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Int J Radiat Oncol Biol Phys 74(4):1047–1053PubMedCrossRefGoogle Scholar
  61. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61(4):212–236PubMedCrossRefGoogle Scholar
  62. Simon E, Fox TH, Lee D, Waller AF, Pantalone P, Jani AB (2009) PET lesion segmentation using automated iso-intensity contouring in head and neck cancer. Technol Cancer Res Treat 8(4):249–255PubMedGoogle Scholar
  63. Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Meredith R (2001) RTOG 96–10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 51(5):1299–1304PubMedCrossRefGoogle Scholar
  64. Taussky D, Dulguerov P, Allal AS (2005) Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas. Head Neck 27(3):182–186PubMedCrossRefGoogle Scholar
  65. Temam S, Pape E, Janot F, Wibault P, Julieron M, Lusinchi A, Mamelle G, Marandas P, Luboinski B, Bourhis J (2005) Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 62(4):1078–1083PubMedCrossRefGoogle Scholar
  66. Troost EG, Schinagl DA, Bussink J, Boerman OC, van der Kogel AJ, Oyen WJ, Kaanders JH (2010) Innovations in radiotherapy planning of head and neck cancers: role of PET. J Nucl Med 51(1):66–76PubMedCrossRefGoogle Scholar
  67. Unger KR, Lominska CE, Deeken JF, Davidson BJ, Newkirk KA, Gagnon GJ, Hwang J, Slack RS, Noone AM, Harter KW (2010) Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 77(5):1411–1419PubMedCrossRefGoogle Scholar
  68. van Asselen B, Raaijmakers CP, Lagendijk JJ, Terhaard CH (2003) Intrafraction motions of the larynx during radiotherapy. Int J Radiat Oncol Biol Phys 56(2):384–390PubMedCrossRefGoogle Scholar
  69. Voynov G, Heron DE, Burton S, Grandis J, Quinn A, Ferris R, Ozhasoglu C, Vogel W, Johnson J (2006) Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol Cancer Res Treat 5(5):529–535PubMedGoogle Scholar
  70. Wadsley JC, Bentzen SM (2004) Investigation of relationship between change in locoregional control and change in overall survival in randomized controlled trials of modified radiotherapy in head-and-neck cancer. Int J Radiat Oncol Biol Phys 60(5):1405–1409PubMedCrossRefGoogle Scholar
  71. Wang JZ, Huang Z, Lo SS, Yuh WT, Mayr NA (2010) A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci Transl Med 2(39):39–48Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Farzan Siddiqui
    • 1
  • David Raben
    • 2
  • Sue S. Yom
    • 3
  • Jiade J. Lu
    • 4
  • Min Yao
    • 5
  1. 1.Department of Radiation OncologyHenry Ford Health SystemDetroitUSA
  2. 2.Department of Radiation OncologyUniversity of Colorado DenverAuroraUSA
  3. 3.Department of Radiation OncologyUniversity of CaliforniaSan FranciscoUSA
  4. 4.Department of Radiation OncologyNational University Cancer Institute of Singapore, National University of SingaporeSingapore
  5. 5.Department of Radiation OncologyUniversity Hospitals Seidman Cancer Center, Case Western Reserve UniversityClevelandUSA

Personalised recommendations